SHR-1316 Clinical Trials
6 recruitingDrug
Phase 26Phase 11
Showing 1–6 of 6 trials
Recruiting
Phase 2
Reverse Triple Negative Immune Resistant Breast Cancer
Fudan University80 enrolled1 locationNCT05076682
Recruiting
Phase 2
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
Breast CancerBreast NeoplasmBreast Tumors
Fudan University716 enrolled1 locationNCT05582499
Recruiting
Phase 1Phase 2
A Study of SHR-1826 for Injection in Combination With Other Antitumor Therapies in Subjects With NSCLC
Non-small Cell Lung Cancer (NSCLC)
Suzhou Suncadia Biopharmaceuticals Co., Ltd.400 enrolled1 locationNCT06754930
Recruiting
Phase 2
A Clinical Study of SHR-A1811 in the Treatment of HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer
HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.54 enrolled2 locationsNCT06778031
Recruiting
Phase 2
A Phase II Study of Triple-negative Breast Cancer Brain Metastases.
Breast Cancer
Fudan University35 enrolled1 locationNCT04303988
Recruiting
Phase 2
Immune Therapy in HR-positive/HER2-negative Metastatic Breast Cancer(ENIGMA)-BCTOP-L-M02
Breast CancerMetastatic Cancer
Fudan University338 enrolled1 locationNCT05205200